CCDC89, also known as Coiled-Coil Domain Containing 89, is a protein encoded by the CCDC89 gene in humans. While there is limited information available on CCDC89, proteins with coiled-coil domains often participate in a variety of biological functions, including protein-protein interactions, cell division, and cellular organization. Such proteins often contribute to the structural framework of various cellular compartments and are involved in the mediation of various signaling pathways.
CCDC89 might be involved in cellular processes such as cell cycle regulation, cell differentiation, or immune responses, based on the general functions of coiled-coil domain proteins. However, the specific roles and regulatory mechanisms of CCDC89 remain largely unexplored and warrant further research to elucidate its precise function and involvement in cellular and physiological processes. Investigating the expression patterns, interaction partners, and functional roles of CCDC89 in various cell types and conditions could provide insights into its biological significance and involvement in health and disease. Further studies could also explore the possibility of targeting CCDC89 for interventions in diseases where it may play a critical role. Thus, CCDC89 represents an area of exploration in cell biology and medical research, where ongoing studies will unveil its functional relevance.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin, also called Sirolimus, might inhibit the expression of CCDC89 by interfering with cellular proliferation and immune response pathways. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By affecting DNA methylation, 5-Azacytidine could hypothetically modify the expression of CCDC89. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D could bind to DNA and block the transcription of CCDC89. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
It might block the translation process, hence affecting the expression of CCDC89 protein. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG132 might inhibit proteasomal activity, affecting protein turnover including CCDC89. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
As a JNK inhibitor, SP600125 might affect various cellular processes including the expression of CCDC89. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
By inhibiting ROCK, it might affect cellular functions and potentially the expression of CCDC89. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
By inhibiting p38 MAPK, it might influence the expression of CCDC89. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
An MEK inhibitor that might affect MAPK signaling pathways and hence CCDC89 expression. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $153.00 $520.00 | 4 | |
By affecting Wnt signaling, it could potentially modify the expression of CCDC89. | ||||||